Judges
The Sternfels Prize has assembled an elite group of judges with substantial medical, pharmacological, and research experience. The panel will review finalist submissions on a blinded basis and select a winner that best meets the competition’s criteria.
 |
 |
 |
 |
David J. Greenblatt, MD, FCP |
Mark J. Ratain, MD |
Kelly E. Caudle, PharmD, PhD |
Jay K. Varma, MD |
The Louis Lasagna, MD, Endowed Professor of Integrative Physiology & Pathology |
Leon O. Jacobson Professor of Medicine |
CPIC Director and Co-PI |
Professor, Department of Population Health Sciences |
Tufts University |
University of Chicago |
St. Jude Children’s Research Hospital |
Weill Cornell Medical School |
Professor David J. Greenblatt, MD, FCP
The Louis Lasagna, MD, Endowed Chair of Integrative Physiology & Pathology
Tufts University
Mark J. Ratain, MD
Leon O. Jacobson Professor of Medicine
University of Chicago
Kelly E. Caudle, PharmD, PhD
CPIC Director and Co-PI
St. Jude Children’s Research Hospital
Jay K. Varma, MD
Professor, Department of Population Health Sciences
Weill Cornell Medical School
2020 Judging Session
From left to right: Dan Roden, Issam Zineh, David Greenblatt
2019 Judging Session
From left to right: Dan Roden, Issam Zineh, David Greenblatt
2018 Judging Session
From left to right: Dan Roden, David Greenblatt, Wayne (Nick) Nicholson, and Larry Lesko
In Memoriam
Darrell R. Abernethy MD, PhD
November 2, 1949 - November 18, 2017
Dr. Darrell Abernethy was a giant in his field. Most recently he served as Associate Director for Drug Safety at the FDA and held appointments at multiple academic institutions and the NIH over his career. Dr. Abernethy contributed heavily to the field of pharmacology and was a career long student and champion of drug safety. He was an ardent supporter of the Sternfels Prize from its inception. Despite being an expert’s expert himself, Dr. Abernethy strongly believed in the ‘wisdom of the crowd’ and that there were individuals from many professions who may be positioned to develop the idea that unlocks another major discovery in drug safety. His absence will be felt on the panel and in the field. To learn more about Dr. Abernethy and all the lives he touched, read his tribute from Dr. Greenblatt in the February edition of Clinical Pharmacology in Drug Development.